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Background: Patients undergoing transurethral resection (TUR) of the prostate are at risk of TUR syndrome,
generally defined as having cardiovascular and/or neurological manifestations, along with serum sodium
concentrations less than or equal to 125 mmol/l. As these symptoms can also occur in patients with serum
sodium greater than 125 mmol/l, this study aimed to investigate the relationship between serum sodium
concentrations and neurological manifestations of TUR syndrome.
Methods: Data on patients who underwent TUR of the prostate under local anesthesia over an 8-year period were
retrospectively reviewed. Based on their cardiovascular and neurological manifestations, patients were divided into
two groups: a symptomatic and an asymptomatic group. Logistic regression analysis was used to detect the risk
factors for being symptomatic. Receiver operator characteristic (ROC) curve analysis was used to determine the
optimal cutoff value of estimated change in serum sodium level that could predict the development of clinical
manifestation of TUR syndrome.
Results: Of the 229 patients, 60 showed symptoms. Serum sodium level correlated with neurological score
(Spearman’s correlation coefficient > 0.5). Logistic regression detected that the risk factors for being symptomatic
were serum sodium level variables, operation time longer than or equal 90 min, and presence of continuous
drainage from the bladder. ROC curve analysis showed that a change in serum sodium level of 7.4 mmol/l was the
optimal cutoff value, with a sensitivity of 0.72, a specificity of 0.87, and an area under the curve (AUC) of 0.87. ROC
curve analysis also showed that a 7.0% change in serum sodium level was optimal for this parameter, with a
sensitivity of 0.70, a specificity of 0.89, and an AUC of 0.87.
Conclusions: Changes in serum sodium concentration of > 7 mmol/l and of > 7% could predict the development
of cardiovascular and neurological manifestations, which were assumed to be symptoms of TUR syndrome.
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The incidence of prostate gland enlargement increases
with age, occurring in an estimated 50% of males at age
60 years and an estimated 90% at 85 years [1]. Prostatic
ultrasonography is used to assess the weight, shape, and
structure of the prostate gland and to determine optimal
treatment. Transurethral resection of the prostate
(TURP) is a standard surgical method used to treat* Correspondence: ane052@poh.osaka-med.ac.jp
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unless otherwise stated.patients with prostate gland enlargement. Our use of
monopolar electrodes as electrical cautery for excision
increases the necessity of using nonconductive irrigation
fluid. These fluids, however, contain no electrolytes,
allowing their absorption into the blood stream. This
may result in dilutional hyponatremia, which may result
in cardiovascular and/or neurological manifestations.
In general, transurethral resection (TUR) syndrome is
defined as a serum sodium concentration ≤ 125 mmol/l
combined with clinical cardiovascular and neurological
manifestations [2,3]. Based on this definition, the rate of
TUR syndrome has been found to range between 0.5%is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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TUR syndrome may occur in patients with serum so-
dium levels > 125 mmol/l.
Theoretical risk factors for TUR syndrome include
surgical release of the prostatic sinus, high irrigation
pressure, prolonged operation time, and use of hypo-
tonic perfusate [2,5]. Moreover, the incidence of TUR
syndrome may be significantly higher if surgery takes
longer than 90 minutes, if the prostate gland weight is
over 45 g, or if patients have acute dysuria, are over
80 years old, or of African race [2,5]. This study investi-
gated whether intra- and post-operative changes in
serum sodium concentrations could predict the clinical
manifestations of TUR syndrome.
Methods
Records of patients who underwent TURP under local
anesthesia at our hospital from 2006 to 2013 were retro-
spectively reviewed. The study protocol was approved by
the Ethics Committee of Osaka Medical College (reference
number 898), which waived the requirement for informed
consent due to the retrospective design of the study.
Preoperative spinal anesthesia was achieved via admin-
istration of 0.5% bupivacaine hydrochloride (2.0–3.0 ml)
at L3/4 or L4/5, resulting in analgesia up to thoracic
level 10 (T10). If spinal anesthesia was ineffective, the
patient was removed from the study. If the anesthetized
region was lower than the T10 sensory levels or operation
time was longer than 1.5 h, 0.375% ropivacaine hydrochlor-
ide (3.0–5.0 ml) was administrated as epidural anesthesia
through a catheter at L1/2 or L2/3, followed by continuousTable 1 Severity score checklist for symptoms of transurethra
Severity score 1
Circulatory
Chest pain Duration < 5 min
Bradycardia HR decrease 10–20 bpm
Hypertension SAP up 10–20 mmHg
Hypotension SAP down 30–50 mmHg
Poor urine output Diuretics needed
Neurological
Blurred vision Duration < 10 min
Nausea Duration < 5 min
Vomiting Single instance
Uneasiness Slight
Confusion Duration < 5 min
Tiredness Patient says so
Consciousness Mildly depressed
Headache Mild
A checklist used to define and score the clinical manifestations of transurethral rese
HR, heart rate; SAP, systolic arterial pressure.administration of 0.2% ropivacaine hydrochloride (2–5 ml/
h) through the postoperative period. Patients with pre-
operative urethral bleeding disorders, renal insufficiency, or
contraindications to spinal anesthesia were excluded.
Irrigation bags filled with 3% D-sorbitol, a non-
conductive irrigation fluid for surgery, were fixed at a
height of 90 cm above the operating table. Heart rate, elec-
trocardiogram, and percutaneous oxygen saturation were
measured and monitored continuously. Systolic blood
pressure (SBP) and diastolic blood pressure (DBP) were
measured every 2 min. All patients were administered
Ringer’s solution, except for those requiring transfusions.
Cardiovascular and neurological manifestations of
TUR syndrome were assessed as described by Hahn
et al. [6]. As shown in Table 1, cardiovascular manifesta-
tions included chest pain, bradycardia, and hypertension.
Neurological manifestations included blurred vision,
nausea, vomiting, uneasiness, confusion, tiredness, con-
sciousness, and headache. In the patients of this study,
we detected nausea, vomiting, restlessness, confusion,
abdominal discomfort, and abdominal pain. As blurred
vision, consciousness, and headache were difficult to as-
sess, uneasiness and tiredness were included under the
category of restlessness. Patients with a > 30% increase in
blood pressure relative to preoperative levels measured
just before local anesthesia was performed in the operat-
ing room, SBP < 80 mmHg, bradycardia, or arrhythmia
were immediately treated to avoid further deterioration.
Patients with SBP < 80 mmHg were immediately admin-
istered 4 mg of ephedrine hydrochloride intravenously.
The medical and nursing staff closely monitored patientsl resection syndrome
2 3
Duration > 5 min Repeated attacks
HR decrease > 20 bpm Repeated decreases
SAP up > 30 mmHg Score (2) for 15 min
SAP down > 50 mmHg Repeated drops > 50 mmHg
Repeated use Diuretics ineffective
Duration > 10 min Transient blindness
Duration 5–120 min Intense or > 120 min
Repeatedly, < 60 min Repeatedly, > 60 min
Moderate Intense
Duration 5–60 min Duration > 60 min
Objectively exhausted Exhausted for > 120 min
Somnolent < 60 min Needs ventilator
Severe < 60 min Severe > 60 min
ction syndrome [6].
Table 2 Baseline demographic and clinical characteristics







Age, yr 72 ± 8 70 ± 7 0.146
Height, cm 164.6 ± 6.2 164.8 ± 6.0 0.788
Body weight, kg 62.9 ± 10.0 63.2 ± 9.5 0.862
Diabetes mellitus 4 (66.7%) 11 (6.5%) 1.000
Hypertension 6 (10.0%) 14 (8.3%) 0.395
Arrhythmia 1 (1.7%) 1 (0.6%) 0.456
Preoperative blood data
Creatinine, mg/dl 0.9 ± 0.2 0.9 ± 0.2 0.861
BUN, mg/dl 16.6 ± 6.1 15.7 ± 4.1 0.619
Sodium, mmol/l 140.8 ± 2.1 140.7 ± 2.3 0.963
Hemoglobin, g/dl 13.6 ± 1.5 14.0 ± 1.5 0.078
Estimated prostatic
grand size, g
87.8 ± 41.8 64.9 ± 26.6 <0.001
Data expressed as mean ± SD or number (%). Transurethral resection
syndrome was defined as the presence of central nervous system disturbances
such as nausea, vomiting, restlessness, pain, confusion, or even coma with
circulatory abnormalities both intra- and post-operatively.
Asymptomatic, patients with no signs of transurethral resection syndrome;
Symptomatic, patients with signs of transurethral resection syndrome; BUN,
blood urea nitrogen.
Table 3 Operative and postoperative data for patients








23 (38.3%) 16 (9.5%) <0.001
0.5% Bupivacaine, ml 2.5 ± 0.4 2.5 ± 0.3 0.117
Resection weight, g 47.5 ± 29.6 31.1 ± 20.0 <0.001
Operation time, min 108 ± 35 85 ± 35 <0.001
Infusion volume, ml 909 ± 508 635 ± 346 <0.001
Infusion and transfusion
volume, ml
1107 ± 609 697 ± 385 <0.001
Diuretics 7 (11.7%) 1 (0.6%) <0.001
Sodium chloride 1 (1.7%) 0 (0.0%) 0.143
Symptoms 60 (100.0%) - NA
Restlessness 28 (46.7%) - NA
Vomiting 22 (36.7%) - NA
Nausea 36 (60.0%) - NA
Pain 17 (28.3%) - NA
Confusion 13 (21.7%) - NA
Postoperative blood data
Creatinine, mg/dl 0.9 ± 0.3 0.9 ± 0.2 0.774
BUN, mg/dl 12.9 ± 5.2 13.0 ± 4.0 0.368
Sodium, mmol/l 134.8 ± 6.8 138.2 ± 3.4 <0.001
Hemoglobin, g/dl 11.0 ± 1.8 12.7 ± 1.6 <0.001
Operative and postoperative
blood data
Minimum hemoglobin, g/dl 10.8 ± 2.0 12.4 ± 1.9 <0.001
Minimum sodium, mmol/l 125.2 ± 10.5 136.9 ± 4.5 <0.001
Minimum sodium
≤125 mmol/l
29 (48.3%) 5 (3.0%) <0.001
Change in sodium
level, mmol/l
14.9 ± 10.3 3.8 ± 4.5 <0.001
Percent change in
sodium level, %
10.6 ± 7.3 2.7 ± 3.2 < 0.001
Data expressed as mean ± SD or number (%). Transurethral resection
syndrome was defined as the presence of central nervous system
disturbances, such as nausea, vomiting, restlessness, pain, confusion, or even
coma, with circulatory abnormalities both intra- and post-operatively.
NA, not applicable; BUN, blood urea nitrogen.
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cations. Intraoperative anesthetic charts and postoperative
nursing charts contained detailed records of each patient’s
status. Manifestations of TUR syndrome were differenti-
ated from manifestations of vasovagal reflux caused by fill-
ing of the bladder or by spinal and/or epidural anesthesia.
Venous blood samples were obtained at least once in-
traoperatively, as well as 3 h after the end of surgery. If
any neurological manifestations were observed, blood
gas analysis was performed several times to treat hypo-
natremia, thus avoiding further deterioration.
Neurological score was defined as the total number
of neurological manifestations, including restlessness,
nausea, vomiting, pain, and confusion. The correlation
between serum sodium levels and neurological scores
was investigated.
Patients were divided into two groups: those with and
without clinical manifestations of TUR syndrome. Fac-
tors compared in these two groups included patients’
demographic characteristics, weight of the resected
prostate, operating time, infusion and transfusion vol-
umes, manifestations of TUR syndrome, postoperative
blood test results, and whether the irrigation fluid was
or was not continuously drained through a suprapubic
pigtail drainage catheter (C. R. Bard, Inc., Karlsruhe,
Germany) [7].
Parameters in patients with and without symptoms of
TUR syndrome were compared using Mann–Whitney Utests, unpaired t-tests, Fisher’s exact tests, and chi-
squared tests, as appropriate. Spearman’s correlation
coefficient was calculated to evaluate the relationship
between neurological scores (defined as the total number
of neurological manifestations, including restlessness, nau-
sea, vomiting, pain, and confusion) and changes in serum
sodium levels. Receiver operator characteristic (ROC)
curve analysis was performed to determine the predictive
value and optimal cutoff point of change in serum sodium
level for the clinical manifestations of TUR syndrome. A p
Figure 1 Correlations between neurological scores and serum sodium levels. Clinical neurological manifestations showed (A) an inverse correlation
with minimum sodium level (Spearman’s correlation coefficient −0.59), and positive correlations with (B) changes in absolute sodium levels
(Spearman’s correlation coefficient 0.58) and (C) percent changes in serum sodium levels (Spearman’s correlation coefficient 0.60). All p values were
less than 0.001.
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statistical analyses were performed using GraphPad Prism
version 5.0 for Mac (GraphPad Software, San Diego, CA,
USA). Univariate logistic regression analyses were per-
formed for parameters judged to be risk factors for TUR
syndrome in the literature [7], including age, body weight,
and operating time, and so on. Only observational vari-
ables with p < 0.05 in univariate analyses were included in
the logistic regression model to ascertain their independ-
ent effects on the symptom occurring. The odds ratio and
p values were calculated for each variable. Again a p value
of < 0.05 was considered statistically significant. The logis-
tic regression analyses were performed with SPSS version
22.0 for Mac (SPSS, Chicago, IL, USA).Table 4 Results of logistic regression analyses of risk factors
Parameter P value Odds ratio 95
Set1
Resected weight≧46 g 0.944 1.03 0.
Operating time≧90 min 0.006 3.31 1.
Minimum sodium ≦125 mmol/l <0.001 34.66 11
Continuous irrigation fluid drainage <0.001 9.62 3.
Set2
Resected weight≧46 g 0.664 0.82 0.
Operating time≧90 min 0.024 2.61 1.
Change in sodium level ≧7 mmol/l <0.001 14.76 6.
Continuous irrigation fluid drainage <0.001 6.08 2.
Set3
Resected weight≧46 g 0.968 0.98 0.
Operating time≧90 min 0.015 2.77 1.
Percent change in sodium level≧7% <0.001 15.36 6.
Continuous irrigation fluid drainage <0.001 6.90 2.Results
Of the 229 patients included in this study, 60 (26.2%)
developed clinical manifestations of TUR syndrome and
169 (73.8%) did not. Most cardiovascular abnormalities
were hypertension with reflex bradycardia, or sudden
hypotension, which is in agreement with our previous
findings [8]. Baseline demographic and clinical charac-
teristics were similar in symptomatic and asymptomatic
patients, except for preoperatively estimated prostatic
grand size (Table 2). However, the two groups showed
significant differences in the duration of surgery, weight
of resected specimen, volumes of intravenous infused
liquid and transfused blood volume, continuous drainage
of irrigation fluid via suprapubic cystostomy, minimumfor transurethral resection syndrome

















Figure 2 Receiver operating characteristic (ROC) curves showing the ability of change in serum sodium level to predict clinical manifestations of
transurethral resection syndrome. ROC analysis showed that the optimal cutoff value for change in serum sodium concentration was 7.4 mmol/l,
and that the optimal cutoff value for percent change was 7.0%. All the numerical information are given in Table 5.
Table 5 Results of receiver operating characteristics (ROC)




AUC Sensitivity Specificity P value
Change in serum
sodium
7.4 mmol/l 0.87 0.72 0.87 < 0.001
Percent change
in serum sodium
7.0% 0.87 0.70 0.89 < 0.001
AUC, area under the ROC curve.
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sampling (Table 3). Minimum serum sodium level means
the smallest amount of sodium detected in each patient in
the intraoperative and postoperative period. Eight patients
required sedatives, diuretic drugs, and/or sodium to alleviate
these symptoms and correct their hyponatremia. Patients
with severe symptoms such as confusion required additional
intravenous anesthetic agents with appropriate airway man-
agement. In addition, of the 195 patients who maintained a
normal sodium level in the intra- and post-operative
period, 31 patients showed symptoms. Of the 34 patients
with sodium level less than or equal 125 mmol/l, five
patients did not show any symptoms.
Serum sodium levels in the symptomatic and asymp-
tomatic groups were reduced by 14.9 ± 10.3 and 3.8 ±
4.5 mmol/l, respectively. These values were the absolute
values in each patient and they were calculated as (pre-
operative sodium level) – (minimum sodium level). Percent
change was calculated as (absolute value)/(preoperative so-
dium level). The change in serum sodium levels correlated
with clinical neurological manifestations. Neurological
manifestations were inversely correlated with minimum
sodium concentration (Spearman’s correlation coeffi-
cient −0.59), and positively correlated with changes in abso-
lute change of serum sodium concentrations (Spearman’s
correlation coefficient 0.58) and percent change of serum
sodium concentrations (Spearman’s correlation coefficient
0.60) (Figure 1).
The logistic regression results are shown in Table 4.
We made three sets of models to detect the best predict-
ive variable between absolute sodium level, change in so-
dium level, and percent change in sodium level. The risk
factors for symptoms occurring were sodium level vari-
ables, operation time longer than 90 min, and presence
of continuous drainage from bladder.ROC analysis showed that the optimal cutoff value for
change in absolute serum sodium concentration was
7.4 mmol/l, with an area under the ROC curve (AUC) of
0.87, a sensitivity of 0.72, and a specificity of 0.87 (Figure 2,
Table 5). The optimal cutoff value for percent change in
serum sodium level was 7.0%, with an AUC of 0.87, a sen-
sitivity of 0.70, and a specificity of 0.89 (Figure 2, Table 5).Discussion
This study defined clinical manifestations of TUR
syndrome based on the appearance of cardiovascular and
neurological manifestations, and assessed these symptoms
relative to changes in serum sodium level [7,8]. Because of
the difficulty in scoring cardiovascular manifestations of
TUR syndrome, a neurological score system that could in-
dicate the symptomatic severity of hyponatremia was used.
Our ROC analyses found that decreases in serum so-
dium levels > 7.4 mmol/l and > 7.0% were predictive of the
clinical manifestation of TUR syndrome. As normal serum
sodium concentrations are about 135–145 mmol/l, clinical
manifestations may occur even in patients with serum
sodium levels > 125 mmol/l; this indicates that symptoms
of TUR syndrome may develop even when serum sodium
Ishio et al. BMC Anesthesiology  (2015) 15:52 Page 6 of 6levels remain within a normal range. In addition, although
the outcomes of TURP under general and local anesthesia
were previously reported to be similar [9], patients who
undergo TURP under general anesthesia may more readily
develop dilutional hyponatremia owing to the slow ab-
sorption of irrigation fluid into blood vessels [10,11].
Therefore, a long-acting diuretic able to maintain serum
sodium levels, such as tolvaptan, may be optimal for
preventing TUR syndrome.
Logistic regression analysis identified the risk factors
of symptoms occurring as serum sodium level variables,
operation time more than or equal to 90 min, and pres-
ence of continuous drainage from bladder. We evaluated
three predictive variables of serum sodium concentra-
tion. A sodium level less than or equal to 125 mmol/l
had the highest accuracy, therefore, it was the most
appropriate predictive parameter. Change in sodium
level and percent change in sodium level had similar
predictive values.
In this study, we detected several neurological manifes-
tations of TUR syndrome, including restlessness, nausea,
vomiting, pain, and confusion. Visual changes, seizures,
and encephalopathy caused by cerebral edema have been
previously reported [5], but were not observed in this
study. Pain was the most difficult symptom to categorize
as being caused by hyponatremia, as it may be caused by
the surgery itself. Patients reported vague abdominal
pains, accompanied by restlessness or nausea.
Postoperative serum sodium levels were examined 3 h
after the end of surgery. None of the patients received
postoperative diuretics or sodium chloride. Postoperative
serum sodium levels recovered relatively easily. As irri-
gation fluid contains no electrolytes, the absorption of
this fluid into the blood from the bladder can lead to
hyponatremia. Water mainly filters into urine automatic-
ally in postoperative patients. However, some patients
experienced reductions in sodium levels due to abnor-
mal volume shift. Our previous study found that con-
tinuous drainage of irrigation fluid through a suprapubic
cystostomy was an important risk factor for TUR syn-
drome in older patients [7]. Although this continuous
drainage was designed to remove debris, blood, and clots
from the operating field, it may accelerate dilutional hypo-
natremia. In the patients’ backgrounds, there was a signifi-
cant difference between the two groups in preoperatively-
estimated prostate gland size. Prostate gland size was pre-
operatively estimated using ultrasonography, which showed
that the patients in the symptomatic group had larger
prostates than those in the asymptomatic group; this is in
agreement with our previous findings [8].
The major limitation of this study was the inability to
obtain frequent blood samples, as blood was not con-
tinuously sampled during surgery. In addition, clinical
manifestations may have differed in anesthetic andnursing charts, because the detection of restlessness and
nausea is subjective. Cardiovascular manifestations and
pulmonary compromise required aggressive interventions
such as converting from local to general anesthesia, which
may explain our lack of severe neurological scores.
Conclusion
Decreases in serum sodium levels of > 7.4 mmol/l or >
7.0% could predict the development of cardiovascular
and neurological manifestations of TUR syndrome.
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